072020 — Choong Ang Vaccine Laboratory Balance Sheet
0.000.00%
- KR₩95bn
- KR₩74bn
- KR₩46bn
- 88
- 52
- 74
- 85
Annual balance sheet for Choong Ang Vaccine Laboratory, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 22,767 | 21,468 | 17,987 | 27,424 | 29,153 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,410 | 3,442 | 3,401 | 4,502 | 5,183 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 42,342 | 39,844 | 39,590 | 50,561 | 52,450 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 57,891 | 66,091 | 66,969 | 63,272 | 64,421 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 104,979 | 112,952 | 114,859 | 119,593 | 123,275 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12,454 | 14,361 | 13,313 | 12,653 | 12,012 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 17,429 | 19,976 | 19,554 | 19,788 | 19,408 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 87,550 | 92,976 | 95,304 | 99,804 | 103,867 |
Total Liabilities & Shareholders' Equity | 104,979 | 112,952 | 114,859 | 119,593 | 123,275 |
Total Common Shares Outstanding |